Immunofluorescent stainings of PD-1, PD-L1 and myeloid markers.... | Download Scientific Diagram
Frontiers | PD-L1 Distribution and Perspective for Cancer Immunotherapy—Blockade, Knockdown, or Inhibition
Raji-hPD-1 cells | ADCC targets | InvivoGen
Anti-PDL-1 Antibody Treatment Reduces Expression of the Exhaustion Marker PD -1 in T Cells | Biocompare Antibody Review
PD-1-high TILs: a predictive biomarker for ICB in lung cancer
The PD-1 expression balance between effector and regulatory T cells predicts the clinical efficacy of PD-1 blockade therapies | Nature Immunology
Programmed death ligand-1 (PD-L1) as a predictive marker for immunotherapy in solid tumours: a guide to immunohistochemistry implementation and interpretation - ScienceDirect
The roles of PD-1/PD-L1 in the prognosis and immunotherapy of prostate cancer: Molecular Therapy
Mechanistic insight of predictive biomarkers for antitumor PD‑1/PD‑L1 blockade: A paradigm shift towards immunome evaluation (Review)
PD-1/ PD-L1 blockade as a novel treatment for colorectal cancer - ScienceDirect
Cancers | Free Full-Text | Beyond PD-1/PD-L1 Inhibition: What the Future Holds for Breast Cancer Immunotherapy
Collagen promotes anti-PD-1/PD-L1 resistance in cancer through LAIR1-dependent CD8+ T cell exhaustion | Nature Communications
Biomarkers for predicting efficacy of PD-1/PD-L1 inhibitors | Molecular Cancer | Full Text
Tumor cell-intrinsic PD-1 receptor is a tumor suppressor and mediates resistance to PD-1 blockade therapy | PNAS
Inhibitory receptors and ligands beyond PD-1, PD-L1 and CTLA-4: breakthroughs or backups | Nature Immunology
Emerging biomarkers as predictors to anti-PD1/PD-L1 therapies in advanced melanoma. | Semantic Scholar
Expression of tumor cell markers and PD-L1 on primary patient-derived cells - Oncolines B.V.
PD-1 in T-cell activation, exhaustion, and effector function. (A) T... | Download Scientific Diagram
PD-1/PD-L1, What a Powerful Immune Checkpoint-CUSABIO
Biomarkers of response to PD-1/PD-L1 inhibition - ScienceDirect
JCM | Free Full-Text | The Evolving Landscape of Biomarkers for Anti-PD-1 or Anti-PD-L1 Therapy
Role of the tumor microenvironment in PD-L1/PD-1-mediated tumor immune escape | Molecular Cancer | Full Text
High IL-8 correlates with reduced response to PD-1/PD-L1 checkpoint blockade
Cancers | Free Full-Text | Immunotherapy Predictive Molecular Markers in Advanced Gastroesophageal Cancer: MSI and Beyond
Identification and Validation of a PD-L1 Binding Peptide for Determination of PDL1 Expression in Tumors | Scientific Reports
Predictive Markers for the Efficacy of Anti–PD-1/PD-L1 Antibodies in Lung Cancer - ScienceDirect
Coexpression of PD-1, NFB activation, and proliferation marker in... | Download Scientific Diagram
